EUVIMEDEUVIMED entdecken
Crossref

Cartilage Endplate‐Targeted Engineered Exosome Releasing and Acid Neutralizing Hydrogel Reverses Intervertebral Disc Degeneration

Jiawen Zhan, Yongzhi Cui, Ping Zhang, Yuxuan Du, Prisca Hecker, Shuaiqi Zhou, Yupeng Liang, Weiye Zhang, Zhefeng Jin, Yuan Wang, Weihang Gao, Oleksandr Moroz und 3 weitere

Advanced Healthcare Materials · 2025-01 · 14 (2)

DOI: 10.1002/adhm.202403315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 18.11.2024. Verfasst von Jiawen Zhan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100000, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Hydrogels, Exosomes. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cartilage endplate cell (CEPC) and nucleus pulposus cell (NPC) inflammation are critical factors that contribute to intervertebral disc degeneration (IVDD). Recent evidence indicated that iron ion influx, reactive oxygen species (ROS), and the cGAS‐STING pathway are involved in CEPC inflammatory degeneration. Moreover, cytokines produced by degenerating CEPCs and lactic acid accumulation within the microenvironment significantly contribute to NPC inflammation. Consequently, simultaneous alleviation of CEPC inflammation and correction of the acidic microenvironment are anticipated to reverse IVDD. Herein, CEPC‐targeted engineered exosomes loaded with salvianolic acid A are incorporated into a CaCO 3 /chitosan hydrogel, forming a composite gel, CAP‐sEXOs@Gel. Notably, CAP‐sEXOs@Gel shows long local retention, realizes the slow release of CAP‐sEXOs and specific uptake by CEPCs. After uptake by CEPCs, CAP‐sEXOs reduce intracellular iron ion and ROS by inhibiting hypoxia‐inducible factor‐2α (HIF‐2α)/TfR1 expression. Iron ion influx and ROS inhibition contribute to the maintenance of normal mitochondrial function and reduced mtDNA leakage, suppresing the cGAS‐STING pathway. Additionally, the CaCO 3 component of CAP‐sEXOs@Gel neutralizes H + , thereby alleviating NPC inflammation. Collectively, this novel composite hydrogel demonstrates the ability to concurrently inhibit CEPC and NPC inflammation, thereby presenting a promising therapeutic approach for IVDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intervertebral Disc DegenerationHydrogelsExosomesAnimalsHumansReactive Oxygen SpeciesNucleus Pulposus

Stichwörter der Autor:innen

cartilage endplate targetingengineered exosomehydrogelinflammagingintervertebral disc degeneration

Substanzen

HydrogelsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Orthopedics, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100000, China.
  • Department of Orthopaedics, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Department of Cognitive Science, University of California, La Jolla, San Diego, California, 92093, USA.
  • Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China.
  • Department of Thyroid and Breast, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510000, China.

ORCID-Profile: Liguo Zhu

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Zhan, J., Cui, Y., Zhang, P., Du, Y., Hecker, P., Zhou, S., Liang, Y., Zhang, W., Jin, Z., Wang, Y., Gao, W., Moroz, O., Zhu, L., Zhang, X., & Zhao, K. (2025). Cartilage Endplate‐Targeted Engineered Exosome Releasing and Acid Neutralizing Hydrogel Reverses Intervertebral Disc Degeneration. Advanced Healthcare Materials, 14(2). https://doi.org/10.1002/adhm.202403315

Vancouver

Zhan J, Cui Y, Zhang P, Du Y, Hecker P, Zhou S, et al. Cartilage Endplate‐Targeted Engineered Exosome Releasing and Acid Neutralizing Hydrogel Reverses Intervertebral Disc Degeneration. Advanced Healthcare Materials. 2025;14(2). doi:10.1002/adhm.202403315

BibTeX
@article{Zhan2025,
  author = {Zhan, Jiawen and Cui, Yongzhi and Zhang, Ping and Du, Yuxuan and Hecker, Prisca and Zhou, Shuaiqi and Liang, Yupeng and Zhang, Weiye and Jin, Zhefeng and Wang, Yuan and Gao, Weihang and Moroz, Oleksandr and Zhu, Liguo and Zhang, Xiaoguang and Zhao, Ke},
  title = {Cartilage Endplate‐Targeted Engineered Exosome Releasing and Acid Neutralizing Hydrogel Reverses Intervertebral Disc Degeneration},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {2},
  doi = {10.1002/adhm.202403315}
}
Kostenlos starten →